2024年6月最新影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY J ENZYM INHIB MED CH （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.5
52人评分
我要评分
声誉 8.2 影响力 6.5 速度 9.7 | |||||||||||||||||||||||||||||||
| 期刊ISSN | 1475-6366 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
| E-ISSN | 1475-6374 | |||||||||||||||||||||||||||||||
| 2023-2024最新影响因子 （数据来源于搜索引擎） | 5.6 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2024年10月29日：4.082 | |||||||||||||||||||||||||||||||
| 2023-2024自引率 | 8.90%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
| 五年影响因子 | 5.1 | |||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 1.42 | |||||||||||||||||||||||||||||||
| h-index | 61 | |||||||||||||||||||||||||||||||
| CiteScore （ 2024年最新版） |
| |||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||
| 期刊官方网站 | http://www.tandfonline.com/loi/ienz20 | |||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://mc.manuscriptcentral.com/genz | |||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY的语言要求，还能让JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes LetPub与Taylor & Francis签署APC支持服务战略合作协议，选择APC支持服务可享受：多样化支付选项，国税发票，加速发表，京东购物卡福利。了解详情>>> | |||||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ EUR2520; USD2630; GBP2100; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：enzymology、cell biology、chemical biology、microbiology、physiology、pharmacology 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||||
| 通讯方式 | TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXON, OX14 4RN | |||||||||||||||||||||||||||||||
| 出版商 | Informa Healthcare | |||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-生化与分子生物学 | |||||||||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||
| 出版周期 | Bimonthly | |||||||||||||||||||||||||||||||
| 出版年份 | 2002 | |||||||||||||||||||||||||||||||
| 年文章数 | 195点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
| Gold OA文章占比 | 97.77% | |||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 91.79% | |||||||||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2023-2024年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2023年12月最新升级版） | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2022年12月升级版） |
| |||||||||||||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2021年12月旧的升级版） |
| |||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1475-6366%5BISSN%5D | |||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 偏慢,4-8周 | |||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 容易 | |||||||||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ EUR2520; USD2630; GBP2100; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer's disease Author: Zhang, Changjun; Zhang, Yujia; Lv, Yangjing; Guo, Jianan; Gao, Bianbian; Lu, Yi; Zang, Anjie; Zhu, Xi; Zhou, Tao; Xie, Yuanyuan Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 100-117. DOI: 10.1080/14756366.2022.2134358 PubMed DOI |
| 2. | Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes Author: Wang, Lifei; Lu, Dan; Wang, Yan; Xu, Xiaoyan; Zhong, Peihua; Yang, Zhiyong Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 84-99. DOI: 10.1080/14756366.2022.2135511 PubMed DOI |
| 3. | Development of 10-Hydroxycamptothecin-crizotinib conjugate based on the synergistic effect on lung cancer cells Author: Liu, Zhen; Xu, Ye; Guo, Lvqian; Li, Xinran; Gao, Junling; Xie, Weiran; Zhao, Lianbo; Teng, Yuou; Li, Xuejiao; Yu, Peng Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 1-11. DOI: 10.1080/14756366.2022.2132487 PubMed DOI |
| 4. | Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity Author: Fu, Dong-Jun; Wang, Ting Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 166-175. DOI: 10.1080/14756366.2022.2136173 PubMed DOI |
| 5. | Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors Author: Fan, Tiantian; Ji, Yinchun; Chen, Danqi; Peng, Xia; Ai, Jing; Xiong, Bing Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 282-293. DOI: 10.1080/14756366.2022.2148317 PubMed DOI |
| 6. | Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings Author: Dong, Jie; Varbanov, Mihayl; Philippot, Stephanie; Vreken, Fanny; Zeng, Wen-Bin; Blay, Vincent Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 24-35. DOI: 10.1080/14756366.2022.2132486 PubMed DOI |
| 7. | Bioactivity and mechanisms of flavonoids in decreasing insulin resistance Author: Zhou, Min; Konigsberg, William H.; Hao, Canhua; Pan, Yinbo; Sun, Jie; Wang, Xiaojing Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. -. DOI: 10.1080/14756366.2023.2199168 PubMed DOI |
| 8. | Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells Author: Zhang, Guanglong; Tang, Zhenhua; Fan, Sili; Li, Chengpeng; Li, Yan; Liu, Weiqin; Long, Xuesha; Zhang, Wenjing; Zhang, Yi; Li, Zhurui; Wang, Zhenchao; Chen, Danping; Ouyang, Guiping Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. -. DOI: 10.1080/14756366.2022.2163393 PubMed DOI |
| 9. | Discovery of coumaric acid derivatives hinted by coastal marine source to seek for uric acid lowering agents Author: Yang, Yu-Shun; Wang, Bin; Liu, Junzhong; Li, Qin; Jiao, Qin-Cai; Qin, Pei Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. -. DOI: 10.1080/14756366.2022.2163241 PubMed DOI |
| 10. | An overview: metal-based inhibitors of urease Author: Yang, Wei; Peng, Zhiyun; Wang, Guangcheng Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 361-375. DOI: 10.1080/14756366.2022.2150182 PubMed DOI |
|
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
